For the Quarter Ending June 2026
Loratadine Prices in North America
- In the United States, Loratadine prices rose in Q2 2026, influenced by surging production costs and robust consumer spending.
- Loratadine production costs increased as the Producer Price Index rose 5.5% year-over-year in June 2026.
- Global chemical prices, including building block chemicals, rose significantly in Q2 2026 due to geopolitical events.
- Demand for Loratadine was supported by robust retail sales, which grew 6.9% year-over-year in May 2026.
- Consumer Price Index increased 3.5% year-over-year in June 2026, indicating persistent inflation affecting purchasing power.
- The United States unemployment rate was 4.2% in June 2026, supporting stable consumer confidence and health spending.
- Demand for specialty chemicals supporting healthcare expanded in Q2 2026, reflecting optimistic market sentiment.
- Brent crude oil spot prices surged in April 2026, then eased in June 2026, influencing energy and feedstock costs.
Why did the price of Loratadine change in June 2026 in North America?
- Producer Price Index increased 5.5% year-over-year in June 2026, raising Loratadine manufacturing costs.
- Robust retail sales, up 6.9% year-over-year in May 2026, bolstered consumer demand.
- Global chemical prices rose significantly in Q2 2026, impacting overall production expenses.
Loratadine Prices in APAC
- In China, the Loratadine Price Index fell in Q2 2026, due to weakening domestic demand and persistent overcapacity.
- Loratadine production costs increased in June 2026, as the Producer Price Index rose by 4.1% year-on-year.
- Loratadine demand remained subdued in Q2 2026, with retail sales growing 1.0% year-on-year in June 2026.
- Industrial production strengthened by 5.3% year-on-year in June 2026, supporting Loratadine supply stability.
- China's manufacturing index expanded in June 2026, indicating a healthy industrial environment for chemical production.
- Crude oil prices peaked in April 2026 before declining through June 2026, influencing feedstock costs for Loratadine.
- Global oil inventories experienced substantial draws during Q2 2026, impacting overall energy feedstock availability.
- The Consumer Price Index remained low at 1.0% year-on-year in June 2026, reflecting weak consumer inflation.
Why did the price of Loratadine change in June 2026 in APAC?
- Weakened domestic demand in China during Q2 2026 limited Loratadine pricing power.
- Producer Price Index rose 4.1% year-on-year in June 2026, increasing Loratadine production costs.
- Persistent overcapacity in China's chemical industry throughout 2026 contributed to price declines.
Loratadine Prices in Europe
- In Germany, the Loratadine Price Index rose quarter-over-quarter in Q2 2026, driven by increased production costs.
- Loratadine production costs rose in Q2 2026; industrial producer prices increased 2.2% year-on-year in May.
- Demand for pharmaceuticals in Germany strengthened in Q2 2026, driven by an aging population and medical needs.
- Retail sales in Germany increased 1.8% year-on-year in May 2026, supporting OTC Loratadine consumer purchasing.
- The Manufacturing Index showed a contracting trend in June 2026, impacting chemical precursor supply chain stability.
- Industrial production remained unchanged at 0.0% year-on-year in May 2026, reflecting a stagnant manufacturing environment.
- The unemployment rate remained stable at 3.8% in May 2026, sustaining consumer incomes and healthcare product demand.
- Consumer confidence was negative in June 2026, indicating caution in discretionary spending on OTC medications.
- Industry inventories tightened in early Q2 2026 as customers built stocks to hedge against supply risks.
Why did the price of Loratadine change in June 2026 in Europe?
- Industrial producer prices increased 2.2% year-on-year in May 2026, raising manufacturing costs.
- The Consumer Price Index rose 2.3% year-on-year in June 2026, increasing operational expenses.
- Retail sales increased 1.8% year-on-year in May 2026, indicating robust consumer demand.
For the Quarter Ending March 2026
Loratadine Prices in North America
- In United States, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petroleum costs.
- The Loratadine Production Cost Trend increased in March 2026 as producer prices rose 4.0% year-over-year.
- The Loratadine Demand Outlook strengthened in March 2026, supported by 4.0% retail sales growth and 3.3% consumer inflation.
- Industrial production grew 0.7% year-over-year in March 2026, keeping domestic Loratadine active pharmaceutical ingredient supply constrained.
- Steady consumer confidence at 91.8 and 4.3% unemployment in March 2026 supported consistent Loratadine retail purchases.
- The Manufacturing Index expanded in March 2026, reflecting robust procurement activity for Loratadine formulation and packaging.
- Upstream petroleum product prices for Loratadine's toluene solvent surged in Q1 2026 due to Middle Eastern disruptions.
- Import reliance for Loratadine active pharmaceutical ingredients strengthened in Q1 2026, prompting federal actions for onshore production.
- The Loratadine Price Forecast indicated an upward trajectory in Q1 2026 as buyers secured supply before tariffs.
Why did the price of Loratadine change in March 2026 in North America?
- Upstream petroleum product prices for Loratadine's toluene solvent spiked in March 2026 amid shipping disruptions.
- Domestic stockpiles of Loratadine active pharmaceutical ingredients weakened in Q1 2026 due to import reliance.
- Elevated producer prices in March 2026 increased the cost of complex organic synthesis and materials.
Loratadine Prices in APAC
- In China, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging regional toluene feedstock costs.
- The Loratadine Production Cost Trend increased significantly in March 2026 as the Producer Price Index rose by 0.5%.
- The Loratadine Demand Outlook remained relatively stable in March 2026 because the Consumer Price Index increased by 1.0%.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, reducing overall consumer OTC pharmaceutical medication purchases.
- Consumer confidence hit 91.6 in February 2026, which directly dampened preventative seasonal allergy medication retail sales volumes.
- Industrial production grew 5.7% in March 2026, ensuring ample market availability of bulk pharmaceutical chemical manufacturing precursors.
- The Manufacturing Index expanded in March 2026, reflecting increased industrial activity within the regional pharmaceutical formulation sector.
- The Loratadine Price Forecast tracked higher in March 2026 as regional naphtha feedstock inventories depleted very rapidly.
Why did the price of Loratadine change in March 2026 in APAC?
- China toluene feedstock costs surged sharply in March 2026, elevating pharmaceutical active ingredient production expenses.
- Global crude oil prices surged in March 2026, increasing baseline costs for essential petrochemical derivatives.
- Domestic chemical supply tightened as plants reduced operating rates in February 2026, restricting precursor availability.
Loratadine Prices in Europe
- In Germany, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream naphtha costs.
- The Loratadine Production Cost Trend increased in March 2026 as 2.7% CPI inflation elevated operational expenses.
- Despite the rising Loratadine Price Index, producer prices declined by -0.2% in March 2026, easing precursor pressures.
- The Loratadine Demand Outlook remained steady as the Manufacturing Index expanded during March 2026, supporting formulation activity.
- Industrial production stagnated at 0.0% in February 2026, while petrochemical operating rates weakened in March 2026.
- Retail sales grew 0.7% and unemployment held at 4.2% in February 2026, supporting OTC allergy medication purchases.
- The Loratadine Price Forecast stabilized as consumer confidence hit -24.7 in March 2026, prompting shifts toward generics.
- Naphtha feedstock costs surged and regional supply tightened in March 2026 due to severe global supply chain disruptions.
- Import availability from Asia plummeted in Q1 2026, while natural gas energy costs spiked in March 2026.
Why did the price of Loratadine change in March 2026 in Europe?
- Naphtha feedstock costs surged in March 2026 due to Middle East conflicts, elevating production expenses.
- Global supply chains experienced severe disruptions in March 2026, tightening regional petrochemical feedstock availability significantly.
- Natural gas energy costs spiked in March 2026, further increasing the overall chemical manufacturing burden.
For the Quarter Ending December 2025
Loratadine Prices in North America
- In the United States, the Loratadine Price Index rose quarter-over-quarter in Q4 2025, driven by robust consumer spending.
- Loratadine production costs increased in Q4 2025, influenced by a 3.0% year-over-year PPI rise in November 2025.
- Loratadine demand outlook strengthened as retail sales increased by 3.3% year-over-year in November 2025.
- Energy costs for Loratadine production climbed as natural gas spot prices rose in the final months of 2025.
- Consumer confidence, at 89.1 in December 2025, supported spending on healthcare products, boosting Loratadine demand.
- Industrial production increased by 2.0% year-over-year in December 2025, indicating expanding economic activity.
- U.S. business inventories, including retail and wholesale, increased in October 2025, impacting supply dynamics.
- The unemployment rate fell to 4.4% in December 2025, bolstering consumer disposable income and spending.
Why did the price of Loratadine change in December 2025 in North America?
- Rising input costs, evidenced by a 2.7% year-over-year CPI increase in December 2025, pressured Loratadine prices upward.
- Strong consumer spending, with retail sales up 3.3% year-over-year in November 2025, boosted demand for Loratadine.
- Natural gas spot prices rose in late 2025 due to a polar vortex, increasing energy-related production expenses.
Loratadine Prices in APAC
- In China, the Loratadine Price Index fell quarter-over-quarter in Q4 2025, driven by reduced production costs and subdued consumer demand.
- Loratadine production costs declined in December 2025, as the Producer Price Index fell by 1.9% year-on-year.
- Lowering general industrial power rates in China during 2025 also contributed to reduced production costs.
- Loratadine demand was subdued in Q4 2025, with retail sales growing only 0.9% year-on-year in December 2025.
- Weak consumer purchasing power, indicated by a 0.8% CPI in December 2025, impacted OTC medication demand.
- Despite cooled consumer sentiment in Q4 2025, government health expenditure increased in November 2025.
- Loratadine supply expanded in December 2025, supported by an expanding Manufacturing Index and 5.2% industrial production growth.
- Persistent overcapacity in the broader chemical industry during 2025 influenced Loratadine market dynamics.
- Chinese medicine exports, including APIs, showed steadily increasing scales in the first eleven months of 2025.
Why did the price of Loratadine change in December 2025 in APAC?
- Falling Producer Price Index by 1.9% in December 2025 reduced manufacturing input costs.
- Subdued consumer demand, with retail sales growing only 0.9% in December 2025, limited purchasing.
- Persistent overcapacity in the chemical industry during 2025 contributed to competitive pricing.
Loratadine Prices in Europe
- In Germany, the Loratadine Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer input costs in December 2025.
- Loratadine production costs trended downward in Q4 2025, as producer prices declined by 2.5% year-on-year in December 2025.
- The Loratadine demand outlook remained subdued in Q4 2025, reflecting contracting manufacturing activity in December 2025.
- Consumer confidence, at -17.5 in December 2025, negatively impacted Loratadine demand, particularly for OTC products.
- German pharmaceutical output strongly increased in October 2025, contrasting with overall weak chemical demand.
- High natural gas costs continued to challenge Loratadine production in Germany throughout Q4 2025.
- Retail sales grew 1.1% year-on-year in November 2025, offering some support for OTC Loratadine demand.
- Industrial production expanded 0.8% year-on-year in October 2025, providing slight stability to the supply chain.
- A 6.2% unemployment rate and 1.8% CPI in December 2025 pressured Loratadine demand.
Why did the price of Loratadine change in December 2025 in Europe?
- Producer input costs for Loratadine declined by 2.5% in December 2025.
- Negative consumer confidence in December 2025 dampened OTC Loratadine demand.
- High natural gas costs in Q4 2025 pressured overall production expenses.
For the Quarter Ending September 2025
North America
- In the United States, the Loratadine (Micronised) Price Index rose quarter-over-quarter in Q3 2025, driven by rising producer costs.
- Loratadine production costs increased due to a 2.6% rise in Producer Price Index year-over-year in August 2025.
- Demand for lower-cost generic active pharmaceutical ingredients strengthened in the US during Q3 2025, supporting market activity.
- US natural gas prices experienced an overall year-on-year uptick in Q3 2025, impacting manufacturing expenses.
- Retail sales, excluding auto and gas, increased 5.42% year-over-year in September 2025, bolstering demand.
- Raw materials and finished goods inventories for chemicals contracted in Q3 2025, indicating destocking.
- The 4.3% unemployment rate in September 2025 supported consumer purchasing power for over-the-counter products.
- Consumer confidence declined to 94.2 in September 2025, potentially dampening future discretionary spending.
- The Loratadine (Micronised) price forecast suggests continued upward pressure due to sustained demand and costs.
Why did the price of Loratadine (Micronised) change in September 2025 in North America?
- Rising Producer Price Index (2.6% YoY, August 2025) increased Loratadine production costs.
- Robust retail sales (up 5.42% YoY, September 2025) bolstered demand for OTC medications.
- Contracting raw material and finished goods inventories in Q3 2025 tightened supply.
APAC
- In China, the Loratadine (Micronised) Price Index faced downward pressure quarter-over-quarter, influenced by contracting manufacturing.
- Loratadine (Micronised) production costs trended upward in Q3 2025, driven by climbing input and raw material costs.
- Demand for Loratadine (Micronised) faced headwinds from a contracting Manufacturing Index and low consumer confidence.
- Deflationary pressures (CPI -0.3%, PPI -2.3% in September 2025) impacted the Loratadine (Micronised) Price Index.
- Overall chemical industry output rose 6.5% year-on-year in September 2025, despite persistent overcapacity issues.
- Retail sales increased 3.0% year-on-year in September 2025, supporting OTC Loratadine demand despite 5.2% unemployment.
- Raw material inventories for manufacturing declined in July 2025, with the decline narrowing by September.
- The Loratadine (Micronised) Price Forecast suggests continued pressure from weak consumer sentiment and manufacturing contraction.
Why did the price of Loratadine (Micronised) change in September 2025 in APAC?
- Deflationary pressures (CPI -0.3%, PPI -2.3% in September 2025) exerted downward price pressure.
- Contracting manufacturing activity and low consumer confidence (89.6 index) dampened demand in September 2025.
- Rising input costs in Q3 2025 were offset by chemical overcapacity, limiting price increases.
Europe
- In Germany, the Loratadine (Micronised) Price Index fell quarter-over-quarter in Q3 2025, due to lower producer prices in September 2025.
- Loratadine (Micronised) production costs faced downward pressure from a 1.7% decline in producer prices in September 2025.
- Demand outlook for Loratadine (Micronised) was stable, with retail sales up 0.2% in September 2025, despite rising CPI.
- Overall industrial output declined in Q3 2025, with the Manufacturing Index contracting, impacting supply chain efficiency.
- Consumer confidence showed a stabilizing trend in Q3 2025, supporting demand for over-the-counter Loratadine products.
- Elevated raw material costs for the chemical industry in Q3 2025 continued to challenge Loratadine (Micronised) manufacturers.
- Increased chemical imports into Germany in Q3 2025 intensified market competition for Loratadine (Micronised).
- The stable 6.3% unemployment rate in September 2025 indicated constrained consumer purchasing power for health items.
- Loratadine (Micronised) price forecast suggests continued pressure from softening chemical sector pricing and cost optimization efforts.
Why did the price of Loratadine (Micronised) change in September 2025 in Europe?
- Producer prices declined 1.7% in September 2025, reducing manufacturing input costs.
- Overall chemical sector pricing softened in Q3 2025, impacting market dynamics.
- Increased chemical imports into Germany in Q3 2025 intensified market competition.
